方案的比较[J]武汉大学学报:医学版,2013,34(5):770-772.
[8]周明华.慢性阻塞性肺疾病治疗进展[J].中国中西医结合急救杂志,2010,17(2):124-125.
[9]张俊.沙美特罗/氟替卡松联合噻托溴铵治疗COPD稳定期患者的疗效[J].江苏医药,2014,40(13):1593-1594.
[10] O’Donnell D E,Fluge T,Gerken F,et al.Effects oftiotropium on lung hyperinflation,dyspnoea and ezercise tolerance in COPD[J].Eur Respir J,2004,23(7):832-840.
[11]杨文兰,郑卫.吸入沙美特罗替卡松对中重度COPD患者运动耐力的影响[J].中国实用内科杂志,2014,33(S1):55-55.
[12] Gao J,Pleasants R A.Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD[J].Int J Chron Obstruct Pulmon Dis,2015,15(10):775-789.
[13] Hagedorn C,Kässner F,Banik N,et al.Influence of salmeterol/fluticasonevia single versus separate inhalers on exacerbations in severe/very severe COPD[J].Respir Med,2013,107(4):542-549.
[14]郭宝明.吸入糖皮质激素治疗稳定期COPD疗效研究[J].中国医学创新,2014,11(27):31-33.
[15] Peter J.Barnes.Future treatments for chronic obstructive pulmonary disease and its comorbidities[J].The Proceedings of the American Thoracic Society,2008,5(21):857-864.
[16] Podstawka A,Mosiewicz J,Myslinski W,et al.Contemporary opinions Onadmini Stration of inhaled glucocorticosteroids in the treatment of chronic obstructive pulmonary disease[J].Ann Univ Mariae Curie Sklodowska Med,2004,59(2):491-497.
(收稿日期:2015-10-21) (本文编辑:蔡元元)
推荐访问: 吸入 期中 长期 美特 稳定